Polio vaccines are available in two primary forms: the oral polio vaccine (OPV), which contains a weakened form of the ... Key players include Sanofi S.A., GSK plc, Bharat Immunologicals and ...
Bizcommunity on MSN10h
Sanofi-Novavax deal in jeopardy as FDA halts vaccine approvalDr Sara Brenner, the FDA's principal deputy commissioner, has paused the approval process for Novavax's Covid-19 vaccine by ...
Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...
Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of chlamydia infection. The company plans to begin a phase I/II study soon ...
The US Food and Drug Administration (FDA) has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The fast track pathway is designed to ...
Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The E.mbrace study is a ...
The US Food and Drug Administration has granted fast track designation to Sanofi's mRNA vaccine candidate for the prevention of chlamydia infection. The decision was based on the potential of the ...
[email protected] Donna Martin, Global Head of Business Development, Vaccines Partnering, Sanofi, Tel: +1-570-957-4715, Email: [email protected] Not only is Sanofi’s vaccines business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback